strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD)
May 2013
New guidelines will try to strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD).
PPIs are still the mainstay for treating patients with GERD...even though they've been under fire for some possible drawbacks.
PPIs likely increase the risk of Clostridium difficile and other GI infections...and there are questions about a higher risk of pneumonia.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote